B.I. ZAGIDULLIN¹, M.F. MUKHAMADEEV¹, R.B. KARIMOVA¹, N.S. STANICHENKO¹, N.Sh. ZAGIDULLIN²

¹Emergency Hospital, 18 Naberezhnochelninsky Pr., Naberezhnye Chelny, Russian Federation, 423803

²Bashkir State Medical University, 3 Lenin Str., Ufa, Russian Federation, 450000

Zagidullin B.I. ― Head of the Department of Roentgen Surgery Diagnostics and Treatment Techniques, tel. +7-917-917-55-88, e-mail: zb_post@mail.ru

Mukhamadeev M.F. ― Cand. Med. Sc., Chief Doctor, tel. (8552) 30-48-01, e-mail: marat.muhamadeev@tatar.ru

Karimova R.B. ― Deputy Chief Doctor on Medical Work, tel. (8552) 30-48-93, e-mail: Karimova.Rezida@tatar.ru

Stanichenko N.S. ― Head of Cardiology Department №1, tel. (8552) 30-48-44, e-mail: Nailya.Stanichenko@tatar.ru

Zagidullin N.Sh. ― D. Med. Sc., Associate Professor of the Department of Propedeutics of Internal Diseases, tel. +7-962-546-76-22, e-mail: znaufal@mail.ru

Despite the taken measures, the mortality from acute coronary syndrome (ACS) and myocardial infarction remains high. In Naberezhnye Chelny in 2009-2012, a number of structural and technological reforms in the ambulance, urgent care and emergency clinic were implemented: the emergency center for the ACS patients was created, cardiology departments of 2 hospitals were joined, endovascular surgery department was created, logistics of admission department and its interaction with the ambulance were improved, aid at pre- and hospital stages was optimized. The implemented reforms resulted in increasing the availability and timeliness of reperfusion therapy of ACS, enabling the implementation in practice, and an annual increase, the number of percutaneous coronary interventions in ACS, and to reduce the «door-to-balloon» indicator by 45%, which, ultimately, led to the reduction of mortality from acute myocardial infarction from 12.3 to 5.4% in 2010-2016.

Key words: acute coronary syndrome, Emergency Hospital of Naberezhnie Chelny, medical aid organization, mortality.

REFERENCES

1.  Braunwald E. Historical milestones in reperfusion therapy for myocardial infarction. In: Bates E.R. (ed.). Reperfusion therapy for acute myocardial infarction. Informa Healthcare USA Inc. New York, 2008. P. 178.

2.  Rogers W.J., Canto J.G., Lambrew C.T., et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J. Am. Coll. Cardiol, 2000, vol. 36, pp. 2056-63.

3.  Bokeriya L.A., Gudkova R.G. Serdechno-sosudistaya khirurgiya [Cardiovascular surgery]. Moscow: Izd-vo NTsSSKh im. A.N. Bakuleva RAMN, 2010. P. 7.

4.  Keeley E.C., Boura J.A., Grines C.L., et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 23 random-ized trials. Lancet, 2003, vol. 361, pp. 13-20.

5.  Kushner F.G., Hand M., Smith, Jr S.C. et al. 2009 Focused Updates: ACC/AHA Guide-lines for the Management of Patients With ST-Elevation Myocardial Infarction (Updat-ing the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JACC, 2009, vol. 54, pp. 2209.

6.  Widimsky P., Wijns W., Fajadet J. et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur. Heart J, 2010, vol. 31 (8), rr. 943-957.

7.  Wijns W., Kolh P., Danchin N., et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J, 2010, vol. 31 (20), pp. 2501-2555.

8.  Barbarash L.S., Ganyukov V.I. Organizatsiya i taktika provedeniya chrezkozhnogo ko-ronarnogo vmeshatel’stva pri infarkte miokarda s pod»emom segmenta ST [Organization and tactics of percutaneous coronary intervention in myocardial infarction with ST segment elevation]. Ke-merovo, 2012. P. 211.

9.  Antman E.M., Cooper H.A., Gibson C.M. et al. Determinants of improvement in epi-cardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II. Eur. Heart J, 2002, vol. 23, pp. 928-933.

10.            Armstrong P.W., Boden W.E. Reperfusion paradox in ST-segment elevation myocardial infarction. Ann. Intern. Med, 2011, vol. 20, 155 (6), rr. 389-391.

11.            Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocar-dial infarction patients. Eur. Heart J, 2006, vol. 27, pp. 779-788.

12.           Boersma E., Maas A.C., Deckers J.W., et al. Early TLT in AMI: reappraisal golden hour. Lancet, 1996, vol. 348, pp. 771-5.

13.            Juliard J.M., Feldman L.J., Golmard J.L. et al. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. Am. J. Cardiol, 2003, vol. 91, pp. 1401-5.

14.            Prikaz Ministerstva zdravookhraneniya Respubliki Tatarstan no. 735 ot 23.04.2015 “Ob organizatsii ekstrennoy meditsinskoy pomoshchi vzroslomu naseleniyu pri ostrom infarkte miokarda i nestabil’noy stenokardii v Respublike Tatarstan” [Order of the Ministry of Health of the Republic of Tatarstan No. 735 of 23 April 2015 «On the organization of emergency medical care for the adult population in acute myocardial infarction and unstable angina in the Republic of Tatarstan»], available at: http://base.garant.ru/22534148

15.            Prikaz po Gorodskomu Avtonomnomu Uchrezhdeniyu Zdravookhraneniya “Stantsiya skoroy meditsinskoy pomoshchi” g. Naberezhnye Chelny ot 12.05.2012 goda no. 149/k “Ob utverzhdenii algoritma okazaniya pomoshchi bol’nym s infarktom miokarda i OKS vyezdnymi brigadami” [Order of the City Autonomous Health Institution «Emergency Medical Care Station» Naberezhnye Chelny from 12.05.2012, No. 149 / k «On the approval of the algorithm for assisting patients with myocardial infarction and ACS visiting teams»].

16.            Prikaz UZ Ispolnitel’nogo komiteta g. Naberezhnye Chelny ot 12.05.2012 goda no. 449 “Ob utverzhdenii algoritma okazaniya pomoshchi bol’nym s infarktom mio-karda i OKS, taktike vyezdnykh brigad” [The order of the UZ of the Executive Committee of Naberezhnye Chelny from 12.05.2012, No. 449 «On the approval of the algorithm for rendering assistance to patients with myocardial infarction and ACS, the tactics of visiting brigades»].

17.            Prikaz MZ RT №1008 ot 20.07.2011 “Ob utverzhdenii otraslevoy tselevoy pro-grammy “Obespechenie preparatami patsientov, poluchivshikh vysokotekhnologich-nuyu meditsinskuyu pomoshch’ po profilyu “serdechno-sosudistaya khirurgiya” [Order of the Ministry of Health of the Republic of Tajikistan № 1008 of 20.07.2011 «On approval of the industry-specific program» Provision of drugs to patients who received high-tech medical care for the profile of «cardiovascular surgery»].

18.            Tarantini G., Razzolini R., Napodano M., et al. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient’s mortality risk: 1 h does not fit all. Eur. Heart J, 2010, vol. 31 (6), pp. 676-683.

19.            Armstrong P.W. and WEST Steering Committee. A comparison of pharmacologic thera-py with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocar-dial infarction Therapy) study. Eur. Heart J, 2006, vol. 27 (13), pp. 1530-1538.

20.            ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, available at: http://www.escardio.org/…/esc…/Guidelines_AMI_ST

21.            Fernández-Avilés F., Alonso J.J., Peña G. et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur. Heart J, 2007, vol. 2, pp. 949-960.